Breast/lungcancer
11 – 20 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer : A Target Trial Emulation Using Nationwide Swedish Registry Data
- Contribution to journal › Article
-
Mark
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK : a retrospective analysis
- Contribution to journal › Article
-
Mark
Multi-omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma
- Contribution to journal › Article
-
Mark
Capturing breast cancers’ copy-number landscape in routine pathology : Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond
- Contribution to journal › Article
-
Mark
Molecular profiling of the Basal-like intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
- Contribution to journal › Article
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
- Contribution to journal › Article
